$4.7 Billion is the total value of HHLR ADVISORS, LTD.'s 60 reported holdings in Q2 2023. The portfolio turnover from Q1 2023 to Q2 2023 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| DQ | DAQO NEW ENERGY CORPspnsrd ads new | $80,868,900 | -15.2% | 2,037,000 | 0.0% | 1.72% | +1.8% | |
| ENFUSION INCcl a | $55,821,553 | +6.9% | 4,975,183 | 0.0% | 1.19% | +28.4% | ||
| YSG | YATSEN HLDG LTDads | $35,288,592 | -31.8% | 34,939,200 | 0.0% | 0.75% | -18.1% | |
| DDOG | DATADOG INC | $21,456,678 | +35.4% | 218,100 | 0.0% | 0.46% | +62.6% | |
| FUTU | FUTU HLDGS LTDspon ads cl a | $16,579,011 | -23.4% | 417,187 | 0.0% | 0.35% | -8.1% | |
| NTES | NETEASE INCsponsored ads | $14,474,493 | +9.3% | 149,700 | 0.0% | 0.31% | +31.1% | |
| SOHU | SOHU COM LTDsponsored ads | $8,064,436 | -25.2% | 731,800 | 0.0% | 0.17% | -9.9% | |
| GOSS | GOSSAMER BIO INC | $5,968,849 | -4.8% | 4,974,041 | 0.0% | 0.13% | +14.4% | |
| TUYA | TUYA INCsponsered ads | $3,023,433 | 0.0% | 1,599,700 | 0.0% | 0.06% | +18.5% | |
| ALGS | ALIGOS THERAPEUTICS INC | $2,242,781 | +11.1% | 2,309,764 | 0.0% | 0.05% | +33.3% | |
| MOGU INCspon ads | $2,034,024 | -26.2% | 847,510 | 0.0% | 0.04% | -12.2% | ||
| YS BIOPHARMA CO LTDordinary shares | $1,037,470 | -13.8% | 751,790 | 0.0% | 0.02% | +4.8% | ||
| UXIN LTDspon ads new | $314,163 | -26.8% | 191,563 | 0.0% | 0.01% | -12.5% | ||
| CHINA JO-JO DRUGSTORES INC | $161,293 | -91.1% | 403,334 | 0.0% | 0.00% | -90.6% |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-08-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| BEIGENE LTD | 20 | Q3 2023 | 26.0% |
| JD.COM INC | 20 | Q3 2023 | 13.1% |
| IQIYI INC | 20 | Q3 2023 | 12.3% |
| MONDELEZ INTL INC | 20 | Q3 2023 | 5.9% |
| KINIKSA PHARMACEUTICALS LTD | 20 | Q3 2023 | 1.6% |
| SOHU COM LTD | 20 | Q3 2023 | 0.6% |
| PINDUODUO INC | 19 | Q3 2023 | 16.1% |
| GOSSAMER BIO INC | 19 | Q3 2023 | 2.3% |
| BRIDGEBIO PHARMA INC | 18 | Q3 2023 | 3.4% |
| MELCO RESORTS AND ENTMT LTD | 18 | Q1 2023 | 2.8% |
View HHLR ADVISORS, LTD.'s complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| I-Mab | June 30, 2023 | 15,891,211 | 8.3% |
| BeiGene, Ltd. | February 14, 2023 | 147,043,058 | 10.9% |
| Gossamer Bio, Inc. | February 14, 2023 | 4,974,041 | 5.3% |
| On Holding AG | February 14, 2023 | 5,468,504 | 1.9% |
| Root, Inc. | February 14, 2023 | 138,977 | 1.5% |
| Yatsen Holding Ltd | February 14, 2023 | 300,560,602 | 19.1% |
| iQIYI, Inc. | July 11, 2022 | 149,075,912 | 5.0% |
| Apellis Pharmaceuticals, Inc. | February 14, 2022 | ? | ? |
| Beam Therapeutics Inc. | February 14, 2022 | ? | ? |
| Futu Holdings Ltd | February 14, 2022 | 2 | - |
View HHLR ADVISORS, LTD.'s complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| 4 | 2024-02-01 |
| 13F-HR | 2023-11-14 |
View HHLR ADVISORS, LTD.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.